UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil

Pharmaceutical research, 2000-09, Vol.17 (9), p.1098-1103

2000

Volltextzugriff (PDF)

Synthesis, in Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)Propyl]Adenine (PMPA) Prodrugs

Antiviral chemistry & chemotherapy, 1997-12, Vol.8 (6), p.557-564

1997

Volltextzugriff (PDF)

Prodrugs of peptides and peptidomimetics for improved formulation and delivery

Advanced Drug Delivery Reviews, 1996-05, Vol.19 (2), p.275-286

Oliyai, Reza

1996

Volltextzugriff (PDF)

KINETIC STUDIES OF THE DEGRADATION OF OXYCARBONYLOXYMETHYL PRODRUG OF ADEFOVIR AND TENOFOVIR IN SOLUTION

Nucleosides, nucleotides & nucleic acids, 2001-04, Vol.20 (4-7), p.1295-1298

2001

Volltextzugriff (PDF)

PHARMACOKINETICS OF SALICYLATE ESTER PRODRUGS OF CYCLIC HPMPC IN DOGS

Nucleosides, nucleotides & nucleic acids, 2001-04, Vol.20 (4-7), p.1411-1414

2001

Volltextzugriff (PDF)

Prodrugs of peptides and peptidomimetics for improved formulation and delivery: Low molecular weight prodrugs

Advanced drug delivery reviews, 1996, Vol.19 (2), p.275-286

OLIYAI, R

1996

Volltextzugriff (PDF)

Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs

Pharmaceutical research, 1997-12, Vol.14 (12), p.1824-1829

1997

Volltextzugriff (PDF)

Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution

Pharmaceutical research, 2001-02, Vol.18 (2), p.234-237

2001

Volltextzugriff (PDF)

Prodrugs of peptides and proteins for improved formulation and delivery

Annual review of pharmacology and toxicology, 1993-01, Vol.33 (1), p.521-544

1993

Volltextzugriff (PDF)

8.05 - Viread

Comprehensive Medicinal Chemistry II, 2007, Vol.8, p.53-58

Second Edition, 2007

Volltextzugriff (PDF)

8.06 - Hepsera

Comprehensive Medicinal Chemistry II, 2007, Vol.8, p.59-63

Second Edition, 2007

Volltextzugriff (PDF)

Structural Factors affecting the kinetics of O,N-acyl transfer in potential O-peptide prodrugs

Bioorganic & medicinal chemistry letters, 1995-11, Vol.5 (22), p.2735-2740

1995

Volltextzugriff (PDF)

Aryl ester prodrugs of cyclic HPMPC. I : Physicochemical characterization and in vitro biological stability

Pharmaceutical research, 1999-11, Vol.16 (11), p.1687-1693

1999

Volltextzugriff (PDF)

Stability testing of pharmaceuticals by isothermal heat conduction calorimetry: Ampicillin in aqueous solution

International journal of pharmaceutics, 1991-06, Vol.73 (1), p.33-36

1991

Volltextzugriff (PDF)

Phosphoryloxymethyl carbamates and carbonates : novel water-soluble prodrugs for amines and hindered alcohols

Pharmaceutical research, 1993-09, Vol.10 (9), p.1350-1355

1993

Volltextzugriff (PDF)

Kinetics and mechanism of isomerization of cyclosporin A

Pharmaceutical research, 1992-05, Vol.9 (5), p.617-622

1992

Volltextzugriff (PDF)

Biexponential decomposition of a neuraminidase inhibitor prodrug (GS-4104) in aqueous solution

Pharmaceutical research, 1998-08, Vol.15 (8), p.1300-1304

1998

Volltextzugriff (PDF)

Enhanced chemical stability of the intracellular prodrug, 1-[(( S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, relative to its parent compound, cidofovir

International journal of pharmaceutics, 1999-03, Vol.179 (2), p.257-265

1999

Volltextzugriff (PDF)

The importance of structural factors on the rate and the extent of N,O-acyl migration in cyclic and linear peptides

Pharmaceutical research, 1995-03, Vol.12 (3), p.323-328

1995

Volltextzugriff (PDF)

Kinetics of acid-catalyzed degradation of cyclosporin A and its analogs in aqueous solution

International Journal of Peptide and Protein Research, 1994-03, Vol.43 (3), p.239-247

1994

Volltextzugriff (PDF)

Revance's novel peptide excipient, RTP004, and its role in stabilizing daxibotulinumtoxinA (DAXI) against aggregation

Toxicon (Oxford), 2018-12, Vol.156, p.S72-S73

2018

Volltextzugriff (PDF)

N-Succinyl-(β-alanyl-l-leucyl-l-alanyl-l-leucyl)doxorubicin: An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Journal of medicinal chemistry, 2001-10, Vol.44 (22), p.3750-3753

2001

Volltextzugriff (PDF)

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer : Application to doxorubicin and preliminary in vitro and in vivo studies

Cancer research (Chicago, Ill.), 2001-04, Vol.61 (7), p.2843-2846

2001

Volltextzugriff (PDF)

Chemical pathways of peptide degradation. IV: Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide

Pharmaceutical research, 1993, Vol.10 (1), p.95-102

1993

Volltextzugriff (PDF)

Chemical pathways of peptide degradation. VI: Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides

Pharmaceutical research, 1994-05, Vol.11 (5), p.751-758

1994

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)
Buchkapitel
(2)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil

Synthesis, in Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)Propyl]Adenine (PMPA) Prodrugs

Prodrugs of peptides and peptidomimetics for improved formulation and delivery

KINETIC STUDIES OF THE DEGRADATION OF OXYCARBONYLOXYMETHYL PRODRUG OF ADEFOVIR AND TENOFOVIR IN SOLUTION

PHARMACOKINETICS OF SALICYLATE ESTER PRODRUGS OF CYCLIC HPMPC IN DOGS

Prodrugs of peptides and peptidomimetics for improved formulation and delivery: Low molecular weight prodrugs

Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs

Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution

Prodrugs of peptides and proteins for improved formulation and delivery

8.05 - Viread

8.06 - Hepsera

Structural Factors affecting the kinetics of O,N-acyl transfer in potential O-peptide prodrugs

Aryl ester prodrugs of cyclic HPMPC. I : Physicochemical characterization and in vitro biological stability

Stability testing of pharmaceuticals by isothermal heat conduction calorimetry: Ampicillin in aqueous solution

Phosphoryloxymethyl carbamates and carbonates : novel water-soluble prodrugs for amines and hindered alcohols

Kinetics and mechanism of isomerization of cyclosporin A

Biexponential decomposition of a neuraminidase inhibitor prodrug (GS-4104) in aqueous solution

Enhanced chemical stability of the intracellular prodrug, 1-[(( S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, relative to its parent compound, cidofovir

The importance of structural factors on the rate and the extent of N,O-acyl migration in cyclic and linear peptides

Kinetics of acid-catalyzed degradation of cyclosporin A and its analogs in aqueous solution

Revance's novel peptide excipient, RTP004, and its role in stabilizing daxibotulinumtoxinA (DAXI) against aggregation

N-Succinyl-(β-alanyl-l-leucyl-l-alanyl-l-leucyl)doxorubicin: An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer : Application to doxorubicin and preliminary in vitro and in vivo studies

Chemical pathways of peptide degradation. IV: Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide

Chemical pathways of peptide degradation. VI: Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides

Suchergebnisse filtern